A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use
NCT ID: NCT00784641
Last Updated: 2020-10-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
567 participants
INTERVENTIONAL
2008-11-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens
NCT01192126
A Study to Evaluate a Modified Contact Lens
NCT01391364
One-Day Dispensing Clinical Evaluation of SofLens Daily Disposable Lenses Compared to a Marketed 1 Day Contact Lens
NCT00902850
Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population
NCT00708643
Safety and Efficacy of a Contact Lens for Daily Disposable Use
NCT01365039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Novel Bausch & Lomb Contact Lens
Novel Bausch \& Lomb daily disposable contact lenses
Novel Bausch & Lomb daily disposable contact lenses
Lenses to be worn and replaced daily for 2 weeks.
SofLens
Bausch \& Lomb SofLens daily disposable contact lenses
Bausch & Lomb SofLens daily disposable contact lenses.
Lenses to be worn and replaced daily for 2 weeks.
Acuvue
Johnson and Johnson 1-Day Acuvue Moist contact lenses
Johnson and Johnson 1-Day Acuvue Moist contact lenses
Lenses to be worn and replaced daily for 2 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Novel Bausch & Lomb daily disposable contact lenses
Lenses to be worn and replaced daily for 2 weeks.
Bausch & Lomb SofLens daily disposable contact lenses.
Lenses to be worn and replaced daily for 2 weeks.
Johnson and Johnson 1-Day Acuvue Moist contact lenses
Lenses to be worn and replaced daily for 2 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must have clear central corneas and be free of any anterior segment disorders.
* Subjects must be myopic and require lens correction in both eyes.
Exclusion Criteria
* Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Subjects wearing monovision, multifocal or toric contact lenses.
* Subjects with grade 2 or greater slit lamp findings.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bev Barna
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. James Ferrari
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
496
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.